{"accession":"0001549595-26-000049","article_url":"https://aiswingx.com/p/nrix-2026q3","attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001549595-26-000049/ContractWithCustomerLiabilityCurrent","change":-0.5102389078498294,"cik":1549595,"company":"NURIX THERAPEUTICS, INC.","concept":{"label":"Deferred revenue (current)","label_en":"Deferred revenue (current)","label_ko":"\uc774\uc5f0\uc218\uc775(\uc720\ub3d9)","period_type":"instant","xbrl_tag":"ContractWithCustomerLiabilityCurrent"},"filed_at":"2026-10-13","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/0001549595-26-000049-index.htm","filing_url":"https://aiswingx.com/f/0001549595-26-000049","form":"10-Q","id":"0001549595-26-000049/ContractWithCustomerLiabilityCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-59","unit":"USD","value":8610000.0,"xbrl_fact_id":"f-59"},{"comparative":true,"instant":true,"period_end":"2025-11-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-60","unit":"USD","value":17580000.0,"xbrl_fact_id":"f-60"}],"statement":"NURIX THERAPEUTICS, INC. (NRIX) reported Deferred revenue (current) of USD 8,610,000 as of 2026-08-31 in its 10-Q (accession 0001549595-26-000049, filed 2026-10-13).","ticker":"NRIX","url":"https://aiswingx.com/n/0001549595-26-000049/ContractWithCustomerLiabilityCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-59"}